Investigating the Long Non-Coding RNA Expression Profiles in the development of esophageal cancer: Insights from genomic Analysis
Publish place: Human Genetics and Genomics، Vol: 6، Issue: 2
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 76
This Paper With 13 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JHGG-6-2_001
تاریخ نمایه سازی: 1 شهریور 1403
Abstract:
Background: Esophageal carcinoma (ESCA) is one of the most common types of cancer. ESCA accounted for the sixth leading cause of cancer-related deaths globally. Most patients are diagnosed at late stages of ESCA, with distance metastasis or chemoresistance, which leads to a poor prognosis. Previous studies demonstrated lncRNA presentation and roles in ESCA cells and patients' tissue. It has been proposed that lncRNAs can be considered a new prognostic and diagnostic biomarker in ESCA. In this study, we comprehensively explored the interaction of lncRNAs with miRNAs and mRNAs of the TCGA database and proposed a novel promising biomarker with good diagnostic and prognostic values.
Methods: The public data of RNA-seq, miR-seq, and related clinical data were downloaded from the TCGA database. Differential expression analysis was conducted by “limma” in R. GO, and KEGG signaling pathways were used for enrichments. STRING database was used for PPI analysis. CE-network was constructed by the STAR database in R. Kaplan-Meier survival analysis (log-rank test), and ROC curve analysis was used to indicate the diagnostic and prognostic values of the biomarkers.
Results: Differentially expressed data illustrated that ۴۵.۸% of the total mRNAs in the data related to ESCA patients showed increased expression and ۵۴.۲% decreased expression. The GO and KEGG pathway analysis showed that the differentially expressed mRNAs were enriched in critical biological processes. Important protein-protein interaction hubs were identified. The ceRNA network data demonstrated critical lncRNAs essential in ESCA development, including TMEM۱۶B-AS۱, AC۰۹۳۰۱۰.۳, SNHG۳, and PVT۱. The data revealed that the lncRNA WDFY۳-AS۲, AC۱۰۸۴۴۹.۲, DLEU۲, AC۰۰۷۱۲۸.۱, and AP۰۰۳۳۵۶.۱ are potential diagnostic and prognostic biomarkers in ESCA patients.
Conclusion: Altogether, this study demonstrates lncRNA, miRNA, and mRNA interaction and mentions regulatory networks which can be considered as a therapeutic option in ESCA. In addition, we proposed potential diagnostic and prognostic biomarkers for ESCA patients.
Keywords:
Authors
Mehran Gholamin
Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mojtaba Jafarinia
Department of Biology, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran.
Mohammad Kargar
Department of Microbiology, Jahrom Branch, Islamic Azad University, Jahrom, Iran
Samaneh Talebi
Department of Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran;
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :